Try our mobile app

Published: 2021-03-09 16:20:53 ET
<<<  go to INTT company page
EX-99.2 3 ex_232560.htm EXHIBIT 99.2 ex_232474.htm
 

 

EXHIBIT 99.2

 

i01.jpg

 

inTEST Corporation

FOURTH QUARTER 2020 FINANCIAL RESULTS ANNOUNCEMENT

CONFERENCE CALL SUPPLEMENTAL INFORMATION

MARCH 5, 2021         

 

 

inTEST Corporation (NYSE American: INTT) is providing this Supplemental Information in conjunction with our 2020 fourth quarter press release in order to provide shareholders and analysts with additional information and detail for analyzing our financial results in advance of our quarterly conference call. The conference call will begin today, Friday, March 5, 2021, at 8:30 am EST. To access the conference call, please dial (323) 289-6576 or (800) 437-2398. The passcode for the conference call is 5369295. Please reference the inTEST 2020 Q4 Financial Results Conference Call. In addition, a live webcast will be available on inTEST’s website, www.intest.com under the “Investors” section and a replay of the webcast will be available for one year following the live broadcast.

 

 

The historical roots of inTEST serve the inherently cyclical semiconductor market. In addition, we also serve a number of diversified growth markets for our precision equipment. As the cornerstone of inTEST, the semiconductor market (Semi Market) is an important component of our business. Complementing this market is our ‘Non-Semi’ market, which is referred to as ‘Multimarket.’ ‘Multimarket’ represents our diversification and refers to any markets other than the semiconductor market. This stems from our strategic objective of growing our business in non-semiconductor markets both organically as well as through acquisition. It is important to note that business within our Thermal segment can fall into either ‘Semi’ or ‘Multimarket,’ depending upon how our customers utilize our products or upon their respective applications.

 

Page 1 of 11

 

 

Non-GAAP Financial Measures

 

In addition to disclosing results that are determined in accordance with GAAP, we also disclose non-GAAP financial measures. These non-GAAP financial measures consist of adjusted net earnings (loss), adjusted net earnings (loss) per diluted share, EBITDA, net earnings excluding restructuring and other non-recurring charges and net earnings excluding restructuring and other non-recurring charges per diluted share. Adjusted net earnings (loss) is derived by adding acquired intangible amortization, adjusted for the related income tax expense (benefit), to net earnings (loss). Adjusted net earnings (loss) per diluted share is derived by dividing adjusted net earnings (loss) by diluted weighted average shares outstanding. EBITDA is derived by adding acquired intangible amortization, interest expense, income tax expense, and depreciation to net earnings (loss). Net earnings per diluted share excluding restructuring and other non-recuring charges is derived by adding restructuring and other charges and other non-recurring charges, both tax effected, to net earnings (loss) and net earnings excluding restructuring and other non-recurring charges per diluted share is derived by dividing net earnings excluding restructuring and other non-recurring charges by diluted weighted average shares outstanding. These results are provided as a complement to the results provided in accordance with GAAP. Adjusted net earnings (loss), adjusted net earnings (loss) per diluted share and EBITDA are non-GAAP financial measures presented to provide investors with meaningful, supplemental information regarding our baseline performance before acquired intangible amortization charges as this expense may not be indicative of our current core business or future outlook. Net earnings excluding restructuring and other non-recuring charges and net earnings excluding restructuring and other non-recurring charges per diluted share are non-GAAP financial measures presented to provide investors with meaningful, supplemental information regarding our baseline performance before restructuring and other non-recurring charges as these restructuring and other non-recurring charges may not be indicative of our current core business or future outlook. These non-GAAP financial measures are used by management to make operational decisions, to forecast future operational results, and for comparison with our business plan, historical operating results and the operating results of our peers. A reconciliation from net earnings (loss) and net earnings (loss) per diluted share to adjusted net earnings (loss) and adjusted net earnings (loss) per diluted share, from net earnings (loss) to EBITDA and from net earnings (loss) and net earnings (loss) per diluted share to net earnings excluding restructuring and other non-recurring charges and net earnings excluding restructuring and other non-recurring charges per diluted share, which are discussed in this Supplemental Information, is contained in the tables below. The non-GAAP financial measures discussed in this Supplemental Information may not be comparable to similarly titled measures used by other companies. The presentation of non-GAAP financial measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.

 

Page 2 of 11

 

 

Summary of Business and Financial Highlights

 

Today we reported the following results for the fourth quarter of 2020:

 

 

Bookings were $17.6 million, up 22% from $14.4 million reported for Q3 2020, and up 58% from $11.1 million reported for Q4 2019. Multimarket bookings were 37% of total bookings for Q4 2020, compared to 50% in Q3 2020 and 59% in Q4 2019.

 

Net revenues were $14.9 million, up 3% from $14.4 million reported for Q3 2020, and up 9% from $13.6 million reported for Q4 2019. Multimarket net revenues were 49% of total net revenues for Q4 2020, compared to 49% in Q3 2020 and 55% in Q4 2019.

 

Gross margin was $6.7 million or 45%, compared to $6.5 million or 45% reported for Q3 2020, and up from $6.5 million or 48% reported for Q4 2019.

 

Operating loss was $(484,000), down from operating income of $427,000 reported for Q3 2020 and down from operating income of $596,000 reported for Q4 2019.

 

Net loss was $(380,000) or $(0.04) per diluted share, down from net earnings of $458,000 or $0.04 per diluted share reported for Q3 2020, and down from net earnings of $724,000 or $0.07 per diluted share reported for Q4 2019.

 

Q4 2020 results included restructuring and other non-recurring costs of $1.3M, details of which are included in this Supplemental Information. These charges were primarily related to the restructuring and consolidation of our EMS Products Segment. When tax effected, these charges amounted to $1.1 million or $0.11 per diluted share. Excluding these non-recurring charges, Q4 2020 net earnings would have been $693,000 or $0.07 per diluted share (Non-GAAP).

 

Page 3 of 11

 

 

Summary of Bookings and Net Revenues

 

Bookings by end market served in dollars and as a percentage of total bookings and net revenues by end market served in dollars and as a percentage of total net revenues for the periods presented:

 

($ in 000s)

 

Three Months Ended

 
                                   

Change

                   

Change

 
   

12/31/2020

   

9/30/2020

    $    

%

   

12/31/2019

    $    

%

 

Bookings

                                                                               

Industrial

  $ 3,665       20.8 %   $ 5,206       36.1 %   $ (1,541 )     -29.6 %   $ 3,825       34.3 %   $ (160 )     -4.2 %

Electronic Test

    2,825       16.0 %     1,958       13.6 %     867       44.3 %     2,703       24.3 %     122       4.5 %

Multimarket (Non-Semi)

  $ 6,490       36.8 %   $ 7,164       49.7 %   $ (674 )     -9.4 %   $ 6,528       58.6 %   $ (38 )     -0.6 %

Semi Market

    11,129       63.2 %     7,263       50.3 %     3,866       53.2 %     4,612       41.4 %     6,517       141.3 %
    $ 17,619       100.0 %   $ 14,427       100.0 %   $ 3,192       22.1 %   $ 11,140       100.0 %   $ 6,479       58.2 %
                                                                                 

Net Revenues

                                                                               

Industrial

  $ 4,995       33.7 %   $ 4,220       29.3 %   $ 775       18.4 %   $ 5,248       38.5 %   $ (253 )     -4.8 %

Electronic Test

    2,266       15.2 %     2,836       19.6 %     (570 )     -20.1 %     2,291       16.8 %     (25 )     -1.1 %

Multimarket (Non-Semi)

  $ 7,261       48.8 %   $ 7,056       48.9 %   $ 205       2.9 %   $ 7,539       55.4 %   $ (278 )     -3.7 %

Semi Market

    7,614       51.2 %     7,387       51.1 %     227       3.1 %     6,075       44.6 %     1,539       25.3 %
    $ 14,875       100.0 %   $ 14,443       100.0 %   $ 432       3.0 %   $ 13,614       100.0 %   $ 1,261       9.3 %

 

Fourth quarter 2020 Multimarket bookings were $6.5 million, or 37% of total bookings, compared with $7.2 million, or 50% of total bookings in the third quarter.

 

Fourth quarter 2020 Multimarket net revenues were $7.3 million, or 49% of total net revenues, compared with $7.1 million, or 49% of total net revenues in the third quarter.

 

Top 10 customers represented 35% of year-to-date net revenues as of the end of the fourth quarter and there were no customers that exceeded 10% of net revenues on a year-to-date basis.

 

Net revenues shipped into China for the year ended December 31, 2020 were $5.5 million or 10% of consolidated net revenues.

 

Page 4 of 11

 

 

Summary of Component Material Costs, Cost of Revenues and Gross Margin

 

Component material costs, cost of revenues and gross margin in dollars and as a percentage of total net revenues in the periods presented:

 

($ in 000s)

 

Three Months Ended

 
   

12/31/2020

   

9/30/2020

   

12/31/2019

 

Consolidated

                                               

Component material costs

  $ 5,226       35.1 %   $ 5,033       34.8 %   $ 4,288       31.5 %

Cost of revenues

  $ 8,155       54.8 %   $ 7,993       55.3 %   $ 7,149       52.5 %

Gross margin

  $ 6,720       45.2 %   $ 6,450       44.7 %   $ 6,465       47.5 %

 

Fourth quarter 2020 gross margin was $6.7 million, or 45%, as compared with $6.5 million, or 45%, in the third quarter. The improvement in the gross margin percentage was primarily the result of a reduction in our quarterly accruals for excess and obsolete inventory, which declined from $105,000 or 0.7% of net revenues in third quarter to $35,000 or 0.2% of net revenues in the fourth quarter.

 

Page 5 of 11

 

 

Summary of Results of Operations

 

Results of operations in dollars and as a percentage of total net revenues in the periods presented:

 

   

Three Months Ended

 

(Amounts in 000s, except per share data)

                           

Change

                   

Change

 
   

12/31/2020

   

9/30/2020

    $    

%

   

12/31/2019

    $    

%

 

Net revenues

  $ 14,875       100.0 %   $ 14,443       100.0 %   $ 432       3.0 %   $ 13,614       100.0 %   $ 1,261       9.3 %

Cost of revenues

    8,155       54.8 %     7,993       55.3 %     162       2.0 %     7,149       52.5 %     1,006       14.1 %

Gross margin

    6,720       45.2 %     6,450       44.7 %     270       4.2 %     6,465       47.5 %     255       3.9 %

Selling expense

    1,962       13.2 %     1,747       12.1 %     215       12.3 %     1,955       14.4 %     7       0.4 %

R&D expense

    1,245       8.4 %     1,316       9.1 %     (71 )     -5.4 %     1,211       8.9 %     34       2.8 %

G&A expense

    2,919       19.6 %     2,799       19.4 %     120       4.3 %     2,703       19.8 %     216       8.0 %

Restructuring and other charges

    1,078       7.2 %     161       1.1 %     917       569.6 %     -       0.0 %     1,078    

#DIV/0!

 

Operating expenses

    7,204       48.4 %     6,023       41.7 %     1,181       19.6 %     5,869       43.1 %     1,335       22.7 %

Operating income (loss)

    (484 )     -3.2 %     427       3.0 %     (911 )     -213.3 %     596       4.4 %     (1,080 )     -181.2 %

Other income

    30       0.2 %     6       0.0 %     24       -400.0 %     52       0.4 %     (22 )     42.3 %

Pre-tax income (loss)

    (454 )     -3.0 %     433       3.0 %     (887 )     -204.8 %     648       4.8 %     (1,102 )     -170.1 %

Income tax benefit

    (74 )     -0.5 %     (25 )     -0.2 %     (49 )     -196.0 %     (76 )     -0.6 %     2       -2.6 %

Net income (loss)

  $ (380 )     -2.5 %   $ 458       3.2 %   $ (838 )     183.0 %   $ 724       5.4 %   $ (1,104 )     152.5 %
                                                                                 

Diluted EPS

  $ (0.04 )           $ 0.04                             $ 0.07                          

Weighted Avg Shares - diluted

    10,283               10,288                               10,299                          
                                                                                 

EBITDA

  $ 12       0.1 %   $ 908       6.3 %   $ (896 )     98.7 %   $ 1,111       8.2 %   $ (1,099 )     -98.9 %

 

Page 6 of 11

 

 

Results of Operations Highlights

 

Selling expense increased by 12% sequentially to $2.0 million for the fourth quarter. The $215,000 increase was driven primarily by higher levels of commission expense. To a lesser extent, there were also increases in advertising and third-party installation costs.

 

Fourth quarter Engineering and product development expense decreased 5% sequentially to $1.2 million. The $71,000 decline was primarily driven by reduced levels of spending on product development materials in our Thermal Products segment.

 

General and administrative expense increased 4% sequentially to $3.0 million in the fourth quarter. The $120,000 increase was driven primarily by non-recurring costs related to the GM transition in our EMS Products segment, as well as increased bonus and stock-based compensation expense related to the recent CEO transition. These increases were partially offset by reduced spending on third-party professionals who assist us with compliance-related activities.

 

Restructuring and other charges were $1.1 million in the fourth quarter compared to $161,000 in the third quarter. The fourth quarter restructuring charges were driven primarily by costs associated with the restructuring and consolidation of the manufacturing operations of our EMS Products segment, which totaled $889,000, as well as costs related to a reduction in our Mansfield, MA facility of $189,000. The third quarter restructuring charges were driven primarily by costs associated with our CEO transition. These restructuring and other charges as well as other non-recurring costs are highlighted in the Summary of Non-Recurring Costs that appears later in this Q4 2020 Supplemental Information.

 

Other income was $30,000 in the fourth quarter compared to $6,000 in the third quarter. The increase in other income in the fourth quarter was driven by a gain on sale of fixed assets as well as increased foreign exchange gains during the period.

 

We booked an income tax benefit of ($74,000) in the fourth quarter, reflecting a 16% effective tax rate. This compares to ($25,000) of income tax benefit accrued in the third quarter, which reflected an effective tax rate of (6%). We currently expect that our effective tax rate in 2021 will range from 16% to 18%.

 

For the quarter ended December 31, 2020, we had a net loss of ($380,000) or ($0.04) per diluted share, compared to net earnings of $458,000 or $0.04 per diluted share for the third quarter. Our fourth quarter results reflected non-recurring charges of $1.3 million, which included the $1.1 million in restructuring and other charges previously discussed, and when tax effected these costs amounted to $1.1 million or $0.11 per share. Excluding these non-recurring costs, our fourth quarter net earnings would have been $693,000 or $0.07 per diluted share (Non-GAAP).

 

Diluted weighted average shares outstanding were 10,282,903 for the fourth quarter of 2020. We did not issue any shares of restricted stock, nor did we have any forfeitures of shares of restricted stock and we did not repurchase any shares during the fourth quarter of 2020.

Depreciation expense was $156,000 for the fourth quarter (compared to $164,000 for the third quarter), while acquired intangible amortization was $306,000 (essentially unchanged from $307,000 for the third quarter). Stock-based compensation expense was $191,000 for the fourth quarter of 2020 (compared to $85,000 for the third quarter, which included the impact of the reversal of $117,000 in previously accrued stock-based compensation expense on restricted stock and option awards issued to our former CEO that were forfeited upon his resignation).

 

Page 7 of 11

 

EBITDA decreased from $908,000 for the third quarter to $12,000 reported for the fourth quarter.

 

Balance Sheet and Cash Flow Highlights

 

Cash and cash equivalents at the end of the fourth quarter were $10.3 million, up $804,000 or 9% from September 30, 2020. During the quarter we had cash flow provided by operations of $848,000. Today cash stands at $11.7 million. We currently expect cash and cash equivalents to decline in the first quarter as a result of the payment of 2020 annual bonuses and then increase throughout 2021 before the impacts of any acquisition related activities.

 

Accounts receivable decreased $1.1 million or 12% sequentially to $8.4 million at December 31, 2020 with 52 DSO.

 

Inventories increased $552,000 or 8% sequentially to $7.5 million at December 31, 2020, which corresponded to 130 days of inventory.

 

Capital expenditures during the fourth quarter were $138,000, down from $330,000 in the third quarter. Included in the third quarter capital expenditures was $202,000 for tenant improvements to our Mt. Laurel, NJ facility related to our EMS facility consolidation. We currently expect to spend $230,000 in the first quarter to complete these tenant improvements.

 

The backlog at the end of December was $11.5 million, up $2.7 million or 31% from $8.7 million at September 30, 2020.

 

Page 8 of 11

 

 

Summary of Non-Recurring Costs

 

($ in 000s)

 

Three Months Ended

   

Year Ended

 

Notes

Description

 

3/31/2020

   

6/30/2020

   

9/30/2020

   

12/31/200

   

12/31/2020

   

Costs associated with the CEO transition

                                         

Severance and medical costs

    -       -       133       -       133  

A

Other costs (legal, consulting, reversal of stock based comp)

    -       136       108       20       264    
      -       136       241       20       397    

EMS Restructure and Consolidation

                                         

Restructuring costs (severance, other lease exit costs)

    -       -       -       222       222    

Facility consolidation costs (moving, production start up)

    -       -       14       145       159    

Lease impairment charge

    -       -       -       522       522    

Total EMS Restructure and Consolidation

    -       -       14       889       903  

A

                                           

Corporate restructuring costs

    8       -       -       -       8  

A

Ambrell restructuring costs

    -       38       -       -       38  

A

MA leased space reduction (including lease impairment charge)

    -       -       -       189       189  

A

Ambrell GM relocation costs

    -       -       14       -       14  

A

Other items (including renewal of $50M shelf S-3)

    -       42       57       185       284    

Total Non-Recurring Costs

    8       216       326       1,283       1,833    

Total Restructuring and Other Charges Per Income Statement

    8       38       161       1,078       1,285  

Sum of A

 

Notes - Items noted by "A" above are included in Restructuring and Other Charges in our consolidated statement of operations. The balance of the non-recurrring items above are included in general and administrative expense on our consolidated statement of operations.

 

Net Earnings (Loss) Excluding Non-Recurring Costs (Non-GAAP):

Net Earnings (Loss) (GAAP)

    (1,143 )     170       458       (380 )     (895 )

Diluted Weighted Average Shares Outstanding

    10,220,853       10,258,917       10,287,562       10,282,903       10,256,560  

Net Earnings (Loss) per diluted share (GAAP)

  $ (0.11 )   $ 0.02     $ 0.04     $ (0.04 )   $ (0.09 )
                                         

Tax effected non-recurring costs - $

    7       201       307       1,073       1,588  

- per diluted share

  $ 0.00     $ 0.02     $ 0.03     $ 0.11     $ 0.16  
                                         

Net Earnings (Loss) excluding non-recurring costs (Non-GAAP) - $

    (1,136 )     371       765       693       693  

- per diluted share (Non-GAAP)

  $ (0.11 )   $ 0.04     $ 0.07     $ 0.07     $ 0.07  

 

Page 9 of 11

 

 

Reconciliation of Net Earnings (GAAP) to EBITDA (Non-GAAP)

 

($ in 000s)

 

Three Months Ended

   

Year Ended

 
   

12/31/2020

   

9/30/2020

   

12/31/2019

   

12/31/2020

 
                                 

Net earnings (loss) (GAAP)

  $ (380 )   $ 458     $ 724     $ (895 )

Acquired intangible amortization

    306       307       313       1,233  

Interest expense

    4       4       -       33  

Income tax expense (benefit)

    (74 )     (25 )     (76 )     (336 )

Depreciation

    156       164       150       630  

EBITDA (Non-GAAP)

  $ 12     $ 908     $ 1,111     $ 665  

 

Reconciliation of Net Earnings (Loss) (GAAP) to Net Earnings Excluding Restructuring and Other Non-Recurring Charges (Non-GAAP) and Net Earnings (Loss) Per Diluted Share (GAAP) to Net Earnings Excluding Restructuring and Other Non-Recurring Charges Per Diluted Share (Non-GAAP)

 

($ in 000s)

 

Three Months Ended

   

Year Ended

 
   

12/31/2020

   

9/30/2020

   

12/31/2019

   

12/31/2020

 

Net earnings (loss) (GAAP)

  $ (380 )   $ 458     $ 724     $ (895 )

Less: Restructuring and other charges

    1,078       161       -       1,285  

Less: Other non-recurring charges

    205       165       -       548  

Tax adjustments

    (210 )     (19 )     -       (245 )

Net earnings excluding restructuring and other non-recurring charges (Non-GAAP)

  $ 693     $ 765     $ 724     $ 693  
                                 

Net earnings (loss) per diluted share (GAAP)

  $ (0.04 )   $ 0.04     $ 0.07     $ (0.09 )

Less: Restructuring and other charges

    0.11       0.02       -       0.13  

Less: Other non-recurring charges

    0.02       0.01       -       0.05  

Tax adjustments

    (0.02 )     -       -       (0.02 )

Net earnings excluding restructuring and other non-recurring charges per diluted share (Non-GAAP)

  $ 0.07     $ 0.07     $ 0.07     $ 0.07  

 

Page 10 of 11

 

 

Forward-Looking Statements

 

This Supplemental Information includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements do not convey historical information but relate to predicted or potential future events and financial results, such as statements of our plans, strategies and intentions, or our future performance or goals, that are based upon management's current expectations. Our forward-looking statements can often be identified by the use of forward-looking terminology such as “believes,” “expects,” “intends,” “may,” “will,” “should,” “plans,” “projects,” “forecasts,” “outlook,” “anticipates” or similar terminology. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

 

Such risks and uncertainties include, but are not limited to, any mentioned in this Supplemental Information as well as the impact of the COVID-19 pandemic on our business, liquidity, financial condition and results of operations; indications of a change in the market cycles in the Semi Market or other markets we serve; changes in business conditions and general economic conditions both domestically and globally; changes in the demand for semiconductors; the success of our strategy to diversify our business by entering markets outside the Semi Market; our ability to successfully consolidate our EMS operations without any impacts on customers shipments; the possibility of future acquisitions or dispositions and the successful integration of any acquired operations; our ability to borrow funds or raise capital to finance potential acquisitions; changes in the rates and timing of capital expenditures by our customers; and other risk factors set forth from time to time in our Securities and Exchange Commission filings, including, but not limited to, our annual report on Form 10-K for the year ended December 31, 2019, quarterly reports on Form 10-Q for the quarters ended March 31, 2020,June 30, 2020 and September 30, 2020. Any forward-looking statement made by us in this Supplemental Information is based only on information currently available to us and speaks to circumstances only as of the date on which it is made. We undertake no obligation to update the information in this Supplemental Information to reflect events or circumstances after the date hereof or to reflect the occurrence of anticipated or unanticipated events.

 

###

 

Page 11 of 11